Jeff Yass’s Sonoma Pharmaceuticals, Inc. Warrants SNOAW Stock Holding History

Jeff Yass’s Portfolio SNOAW Stock Details SNOAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-95,541	Closed	-$1K	–	11145
2019 Q3	$1K	Buy	+95,541	New	+$1.22K	﹤0.01%	10072
2019 Q2	–	Sell	-27,170	Closed	–	–	11182
2019 Q1	$0	Buy	+27,170	New	+$598	﹤0.01%	10361
2018 Q3	–	Sell	-27,867	Closed	-$4K	–	10714
2018 Q2	$4K	Buy	+27,867	New	+$7.88K	﹤0.01%	9482
2017 Q2	–	Sell	-10,971	Closed	-$7K	–	10159
2017 Q1	$7K	Sell	10,971 -21,546	-66%	-$10.9K	﹤0.01%	8792
2016 Q4	$12K	Buy	+32,517	New	+$11.9K	﹤0.01%	9465

Jeff Yass's SNOAW Position: Q4 2019 in Review

Jeff Yass sold out of Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) in Q4 2019, closing a stake of 95,541 shares — an estimated $1K sold.

Jeff Yass first reported a position in SNOAW in Q4 2016 and held it in 5 quarters. The position peaked at $12K in Q4 2016. 0 funds tracked by Wall St. Rank hold SNOAW as of Q4 2019.

Jeff Yass reported no remaining Sonoma Pharmaceuticals, Inc. Warrants position as of Q4 2019 after selling out during the quarter.
Jeff Yass sold 95,541 Sonoma Pharmaceuticals, Inc. Warrants shares in Q4 2019, an estimated $1K.
Jeff Yass first reported a position in Sonoma Pharmaceuticals, Inc. Warrants in Q4 2016 and held it in 5 quarters.
Jeff Yass's Sonoma Pharmaceuticals, Inc. Warrants position peaked at $12K in Q4 2016.
0 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals, Inc. Warrants as of Q4 2019.

Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.